APA (7th ed.) Citation

Björholt, I., Andersson, F. L., Kahan, T., & Östergren, J. (2002). The cost‐effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: A Swedish sub‐study to the HOPE study. Journal of internal medicine, 251(6), 508-517. https://doi.org/10.1046/j.1365-2796.2002.00990.x

Chicago Style (17th ed.) Citation

Björholt, I., F. L. Andersson, T. Kahan, and J. Östergren. "The Cost‐effectiveness of Ramipril in the Treatment of Patients at High Risk of Cardiovascular Events: A Swedish Sub‐study to the HOPE Study." Journal of Internal Medicine 251, no. 6 (2002): 508-517. https://doi.org/10.1046/j.1365-2796.2002.00990.x.

MLA (9th ed.) Citation

Björholt, I., et al. "The Cost‐effectiveness of Ramipril in the Treatment of Patients at High Risk of Cardiovascular Events: A Swedish Sub‐study to the HOPE Study." Journal of Internal Medicine, vol. 251, no. 6, 2002, pp. 508-517, https://doi.org/10.1046/j.1365-2796.2002.00990.x.